Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
Pignata, Sandro, Dr, Scambia, Giovanni, Prof, Katsaros, Dionyssios, Prof, Gallo, Ciro, Prof, Pujade-Lauraine, Eric, Prof, De Placido, Sabino, Prof, Bologna, Alessandra, MD, Weber, Beatrice, MD, Raspagliesi, Francesco, MD, Panici, Pierluigi Benedetti, Prof, Cormio, Gennaro, MD, Sorio, Roberto, MD, Cavazzini, Maria Giovanna, MD, Ferrandina, Gabriella, MD, Breda, Enrico, MD, Murgia, Viviana, MD, Sacco, Cosimo, MD, Cinieri, Saverio, MD, Salutari, Vanda, MD, Ricci, Caterina, MD, Pisano, Carmela, MD, Greggi, Stefano, MD, Lauria, Rossella, MD, Lorusso, Domenica, MD, Marchetti, Claudia, MD, Selvaggi, Luigi, Prof, Signoriello, Simona, PhD, Piccirillo, Maria Carmela, MD, Di Maio, Massimo, MD, Perrone, Francesco, MD
Published in The lancet oncology (01.04.2014)
Published in The lancet oncology (01.04.2014)
Get full text
Journal Article